Ploussard, G., Terry, S., Maillé, P., Allory, Y., Sirab, N., Kheuang, L., . . . De La Taille, A. (2010). Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy. American Association for Cancer Research.
Chicago Style CitationPloussard, Guillaume, et al. Class III Beta-tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-based Chemotherapy. American Association for Cancer Research, 2010.
Cita MLAPloussard, Guillaume, et al. Class III Beta-tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-based Chemotherapy. American Association for Cancer Research, 2010.
Atenció: Aquestes cites poden no estar 100% correctes.